Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
Boeing Reaches Tentative Settlement With Canadian Victim’s Family in 737 MAX Crash Lawsuits 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara 
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery 
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive 
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand 
 - EconoTimes)
GAITHERSBURG, Md., April 13, 2017 -- OpGen, Inc. (NASDAQ:OPGN) today announced that five posters featuring its technologies will be presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) being held April 22-25, 2017 in Vienna, Austria. Among them will be a poster presentation titled “Prediction of antibiotic resistance in Escherichia Coli from resistance genes” by Dr. Terry Walker, Senior Vice President of Research and Development at OpGen. The presentation will highlight preliminary results supporting OpGen’s efforts to develop and commercialize a rapid and highly accurate test that predicts antibiotic resistance using resistance gene detection and the bioinformatics capabilities of the Acuitas Lighthouse® Knowledgebase. The OpGen booth location is 32B.
The details for the presentations at ECCMID are as follows:
Poster title: Prediction of antibiotic resistance in Escherichia coli from resistance genes
Presenter: T. Walker, OpGen
Date and time: Tuesday, April 25 from 12:54 - 12:59 pm CEST
Location: Poster Area
Poster number: #EP0938
Abstract number: #4182
Session info: Direct detection methods
Poster title: Use of the Acuitas Resistome Test to detect and type carbapenemase producing organisms (CPOs): A pilot study
Presenter: G. Vanstone, Royal Free London NHS Foundation Trust
Date and time: Saturday, April 22 from 3:30 - 4:30 pm CEST
Location: Poster Area
Poster number: #P0387
Abstract number: #6205
Session info: Detection of resistant pathogens
Poster title: Rapid outbreak detection of multi-drug resistant organisms using resistance genes profiles
Presenter: W. Chang, OpGen
Date and time: Saturday, April 22 from 8:45 am - 3:30 pm CEST
Location: Poster Area
Poster number: #EV0483
Abstract number: #5396
Session info: Resistance surveillance & epidemiology: Gram-negatives
Poster title: Evaluation of QuickFISH and the Sepsityper assays for early identification of aetiological agents in bloodstream infection in a clinical routine setting
Presenter: A. Pernestig, Systems Biology Research Centre, University of Skövde
Date and time: Monday, April 24 from 1:30 - 2:30 pm CEST
Location: Poster Area
Poster number: #P1561
Abstract number: #1166
Session info: Diagnostic microbiology
Poster title: Seven years of clinical experience with the Yeast Traffic Light PNA FISH: assay performance and implications on antifungal therapy
Presenter: V. Özenci, Karolinska University Hospital
Date and time: Sunday, April 23 from 1:30 - 2:30 pm CEST
Location: Poster Area
Poster number: #P0969
Abstract number: #5533
Session info: Diagnostic mycology I
About OpGen
OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection prevention and treatment. Learn more at www.opgen.com and follow OpGen on Twitter and LinkedIn.
OpGen Contact: Michael Farmer Director, Marketing 240-813-1284 [email protected] [email protected] OpGen Investor and Media Contact: MacDougall Biomedical Communications Cammy Duong 781-591-3443 [email protected]
